case_images: PMC11146343_01
case_images: Secukinumab therapy. Before initiation of secukinumab therapy.
case_images: CCID-17-1275-g0001.jpg
case_images: PMC11146343_01_CCID-17-1275-g0001.jpg
case_images: f0001
case_images: After 24 weeks of secukinumab therapy.
case_images: CCID-17-1275-g0002.jpg
case_images: PMC11146343_01_CCID-17-1275-g0002.jpg
case_images: f0002
case_images: Results have been confirmed and improved after 6 months of therapy (DLQI 4, NRS 1 and IHS4 15) (Figure 2).